Morgan Stanley downgraded RenaissanceRe (RNR) to Equal Weight from Overweight with an unchanged price target of $310. The firm cites valuation for the downgrade with the shares up 32% over the last 12 months. RenaissanceRe’s valuation now reflects much of the upside from here, the analyst tells investors in a research note. Morgan Stanley adds that the company faces continued pricing pressure and casualty sector volatility, making a neutral stance more appropriate.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RNR:
- RenaissanceRe price target raised to $333 from $328 at Citi
- RenaissanceRe raises quarterly dividend, renews share repurchase program
- RenaissanceRe price target raised to $312 from $280 at UBS
- RenaissanceRe downgraded to Neutral from Buy at Citi
- RenaissanceRe price target raised to $323 from $314 at Keefe Bruyette
